Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,195
Total Claims
$2.1M
Drug Cost
2,583
Beneficiaries
$802
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-32%
Cost per patient vs peers
$802 vs $1,174 avg
+140%
Brand preference vs peers
21.3% vs 8.9% avg
Brand vs Generic
Brand: 2,472 claims · $1.8M
Generic: 9,157 claims · $218K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 210 | $283K |
| Dulaglutide | 154 | $187K |
| Semaglutide | 108 | $160K |
| Apixaban | 176 | $147K |
| Semaglutide | 123 | $140K |
| Sitagliptin Phosphate | 78 | $90K |
| Rivaroxaban | 66 | $71K |
| Sacubitril/Valsartan | 49 | $61K |
| Insulin Glargine,hum.Rec.Anlog | 145 | $47K |
| Budesonide/Formoterol Fumarate | 108 | $47K |
| Diclofenac Sodium | 301 | $47K |
| Dapagliflozin Propanediol | 30 | $44K |
| Insulin Glargine,hum.Rec.Anlog | 69 | $34K |
| Sitagliptin Phos/Metformin Hcl | 19 | $29K |
| Liraglutide | 18 | $29K |
Prescribing Profile
Patient Profile
73
Avg Age
69%
Female
1.82
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data